On September 9, 2020 Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, reported its participation in the following upcoming virtual investor conferences (Press release, Moderna Therapeutics, SEP 9, 2020, View Source [SID1234564838]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley Virtual 18th Annual Global Healthcare Conference on Monday, September 14, 2020 at 9:00 a.m. ET.
Bank of America Virtual Global Healthcare Conference on Friday, September 18, 2020 at 10:05 a.m. ET.
A live webcast of each presentation will be available under "Events and Presentations" in the Investors section of the Moderna website at View Source A replay of each webcast will be archived on Moderna’s website for 30 days following the presentation.

On September 9, 2020 Onconova Therapeutics, Inc. (NASDAQ: ONTX) a biopharmaceutical company focused on discovering and developing novel products to treat cancer, reported that the Company plans to participate in several upcoming events (Press release, Onconova, SEP 9, 2020, View Source [SID1234564836]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Marcus Evans Healthcare Investment Webinar
Participation on panel titled "Exploring ESG Investment Opportunities in Healthcare amidst COVID-19" on Thursday, September 10 at 1:00 PM ET

H.C. Wainwright 22nd Annual Global Investment Conference
Company presentation on Monday, September 14 at 1:30 PM ET
Webcast information: View Source

2nd Annual RAS-Targeted Drug Development Conference
Company presentation titled "Rigosertib as a Unique Small Molecule RAS Antagonist: Scientific & Clinical Studies" on Wednesday, September 16 at 11:30 AM ET and panel discussion at 12:50 PM ET

On September 9, 2020 EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, reported that management will be presenting at the HC Wainwright Virtual 22nd Annual Global Investment Conference, which is being held September 14-15, 2020 (Press release, EDAP TMS, SEP 9, 2020, View Source [SID1234564835]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation details
Date: Tuesday, September 15
Time: 10:30am EDT
Webcast: View Source

The webcast will be archived and available for replay for a period of 90 days.

On September 9, 2020 TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, reported that the Company’s President Mr. George Yeh and Chief Medical Officer Dr. George Spencer-Green, MD, will be presenting at HC Wainwright & Co’s 22nd Annual Global Investment Conference on Monday, September 14, 2020, at 10:00am ET (Press release, Taiwan Liposome Company, SEP 9, 2020, https://tlcbio.gcs-web.com/news-releases/news-release-details/tlc-present-hc-wainwright-co-22nd-annual-global-investment [SID1234564833]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The 20-minute live presentation will include a company overview and update by Mr. Yeh, with analyses of data on TLC’s pain programs – TLC599 and TLC590 – by Dr. Spencer-Green. During the virtual conference, which will take place September 14-16, 2020, TLC will also be participating in one-on-one sessions.

The corporate slide deck used during the live presentation will be available on the company’s website at www.tlcbio.com in the Investors section, under News & Events.

On September 9, 2020 Genmab A/S (Nasdaq:GMAB) reported that its CEO, Jan van de Winkel, Ph.D. and CFO Anthony Pagano, will participate in a virtual fireside chat at the Morgan Stanley 18th Annual Global Healthcare Conference at 11:45 AM EDT / 5:45 PM CEST on September 15, 2020 (Press release, Genmab, SEP 9, 2020, View Source [SID1234564830]). A webcast of the event, which will include brief opening remarks followed by a question-and-answer session, will be available on Genmab’s website at View Source

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!